Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle

Brixaldi, which was first tentatively approved in late 2018, will be available in September in weekly and monthly dosages.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news